Researchers warn that zolpidem dependence and abrupt withdrawal can be life-threatening
Study with addicted women at Hospital das Clínicas shows severe effects of improper use of insomnia medication and its sudden withdrawal; in 2024, Anvisa (Brazilian Health Regulatory Agency) began requiring a blue prescription (used for medications that can potentially cause addiction) for its sale
Study with addicted women at Hospital das Clínicas shows severe effects of improper use of insomnia medication and its sudden withdrawal; in 2024, Anvisa (Brazilian Health Regulatory Agency) began requiring a blue prescription (used for medications that can potentially cause addiction) for its sale 
